The relation between blood leucocyte count, erythrocyte sedimentation rate, high sensitive C-reactive protein and pulmonary parenchymal infiltration in young male patients with Chlamydia pneumoniae pneumonia Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009
Study of erythrocyte sedimentation rate in patients with pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 309s Year: 2001
Unexpected reduction of erythrocyte sedimentation rate (ESR) following acute administration of high dose of N-acetycysteine Source: Eur Respir J 2005; 26: Suppl. 49, 574s Year: 2005
Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia Source: Eur Respir J 2005; 25: 688-692 Year: 2005
Prognosis value of initial C-reactive protein (CRP) assay in patients with community acquired pneumonia Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
The relation of hemoglobin, hematocrit, leucocyte and platelet levels to the severity of lesion in patients with pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 310s Year: 2001
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA) Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma Year: 2020
Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018 Year: 2018
Procalcitonin as a diagnostic tool in lower respiratory tract infections and tuberculosis Source: Eur Respir J 2003; 21: 939-943 Year: 2003
C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study Source: Eur Respir J 2005; 25: 804-812 Year: 2005
The blood eosinophil count as a biomarker in COPD Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD Year: 2015
C-reactive protein (CRP) at admission: is it really usefull in COVID-19 pneumonia? Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021
The search for the “healthy” blood eosinophil count Source: Eur Respir J, 55 (5) 2000473; 10.1183/13993003.00473-2020 Year: 2020
Mycoplasma pneumoniae infection affects total eosinophil count, the serum level of ECP, and interleukin-5 in atopic childrenSource: Annual Congress 2012 - Airway infections in children: from risk factors to treatment Year: 2012
Level of C-reactive protein in blood serum of patients with MDR tuberculosis before and after treatment Source: Eur Respir J 2007; 30: Suppl. 51, 201s Year: 2007
Determinants of blood eosinophil count in adults from a large population-based study Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
Changes in levels of inflammatory markers (procalcitonin, C-reactive protein) in pregnant with community-acquired pneumonia (CAP) Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016
High-sensitive C-reactive protein is associated with reduced lung function in young adults Source: Eur Respir J 2009; 33: 382-388 Year: 2009
C-reactive protein (CRP) as a marker of disease severity in community acquired pneumonia patients with sepsis Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012